Rosetta Inpharmatics' Unattributed VC - III Round

Rosetta Inpharmatics raised a round of funding on March 17, 2000.

Rosetta Inpharmatics, a wholly owned subsidiary of Merck and Co. Inc., develops and implements technologies that will improve drug discovery.…

Articles about Rosetta Inpharmatics' Unattributed VC - III Round: